Venipuncture

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Vitestro
VitestroNetherlands - Utrecht
1 program
Venipuncture DeviceN/A1 trial
Active Trials
NCT05878483Recruiting13,618Est. Jul 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
VitestroVenipuncture Device

Clinical Trials (1)

Total enrollment: 13,618 patients across 1 trials

NCT05878483VitestroVenipuncture Device

Autonomous Blood Drawing Optimization and Performance Testing

Start: Jul 2023Est. completion: Jul 202513,618 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 13,618 patients
1 companies competing in this space